ICM
NATR icon

Invenomic Capital Management’s Nature's Sunshine NATR Stock Holding History

Invenomic Capital Management’s Portfolio NATR Stock Details NATR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-12,245
Closed -$183K – 143
2020
Q4 		$183K Buy
+12,245
New +$151K 0.05% 127

Other funds holding NATR

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return

Invenomic Capital Management's NATR Position: Q1 2021 in Review

Invenomic Capital Management sold out of Nature's Sunshine (NATR) in Q1 2021, closing a stake of 12,245 shares — an estimated $183K sold.

Invenomic Capital Management first reported a position in NATR in Q4 2020 and held it in 1 quarter. The position peaked at $183K in Q4 2020. 77 funds tracked by Wall St. Rank hold NATR as of Q1 2021.

  • Invenomic Capital Management reported no remaining Nature's Sunshine position as of Q1 2021 after selling out during the quarter.
  • Invenomic Capital Management sold 12,245 Nature's Sunshine shares in Q1 2021, an estimated $183K.
  • Invenomic Capital Management first reported a position in Nature's Sunshine in Q4 2020 and held it in 1 quarter.
  • Invenomic Capital Management's Nature's Sunshine position peaked at $183K in Q4 2020.
  • 77 funds tracked by Wall St. Rank held Nature's Sunshine as of Q1 2021.

Based on Invenomic Capital Management's 13F filing for Q1 2021, filed 13 May 2021.